Company news
Scancell Holdings PLC news in 2021
Scancell Holdings PLC's news releases, calls and decks from 2021, newest first.
First patient dosed in SCIB1 Phase 2 trial
November 19, 2021
Notice of Annual General Meeting
November 1, 2021
Results for the year ended 30 April 2021
October 29, 2021
Extension of CLN Redemption Dates
October 28, 2021
New facilities at The Oxford Science Park
October 19, 2021
First subject dosed in COVIDITY clinical trial
October 5, 2021
PDMR dealing
September 9, 2021
Modi-1 Phase I/II CTA approved by MHRA
August 26, 2021
Scancell selects PharmaJet's Needle-free Systems
August 17, 2021
COVIDITY Phase 1 trial application in SA approved
July 29, 2021
Lindy Durrant appointed CEO of Scancell
July 28, 2021
COVIDITY trial planned in South Africa and UK
June 22, 2021
Appointment of Joint Broker
June 15, 2021
Block listing six monthly return
February 16, 2021
Statement regarding share price movement
February 15, 2021
Update on SCIB2 clinical development partnership
February 3, 2021
Interim Results for the 6 months ended 31 Oct 2020
January 29, 2021
Decks in 2021
- Shareholder Meeting (November 2021)
Shareholder meeting · 41 slides · November 2021